These data provide compelling evidence that enhanced TTLL11-mediated tubulin polyglutamylation can prevent (or delay) the axonal phenotypes caused by defective spastin gene dosage in animal and cellular models of SPG4-linked HSP, revealing an evolutionarily conserved mechanism (see Fig. 10A,B). This evidence concerns the gene SPAST and hereditary spastic paraplegia.